| human | Q5 |
| P1153 | Scopus author ID | 7005109134 |
| P166 | award received | Prix Georges, Jacques et Elias Canetti | Q20723635 |
| P735 | given name | Claude | Q17523984 |
| Claude | Q17523984 | ||
| P21 | sex or gender | male | Q6581097 |
| Q90967187 | 2019 - A year of celebrations |
| Q50461263 | A fluorescent reporter reveals on/off regulation of the Shigella type III secretion apparatus during entry and cell-to-cell spread. |
| Q81785474 | A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri |
| Q40198172 | An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses |
| Q81503204 | Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri |
| Q30579709 | B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection |
| Q80932024 | Cell regulation |
| Q34941907 | Chaperones of the type III secretion pathway: jacks of all trades |
| Q34200118 | Characterization of the promoter, MxiE box and 5' UTR of genes controlled by the activity of the type III secretion apparatus in Shigella flexneri |
| Q24534908 | Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology |
| Q35587382 | Distinct mutations led to inactivation of type 1 fimbriae expression in Shigella spp |
| Q38870471 | Escape of Actively Secreting Shigella flexneri from ATG8/LC3-Positive Vacuoles Formed during Cell-To-Cell Spread Is Facilitated by IcsB and VirA. |
| Q42650994 | Frameshifting by transcriptional slippage is involved in production of MxiE, the transcription activator regulated by the activity of the type III secretion apparatus in Shigella flexneri. |
| Q50026010 | Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes |
| Q34527081 | Identification of substrates and chaperone from the Yersinia enterocolitica 1B Ysa type III secretion system |
| Q39680871 | Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri |
| Q38636542 | Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes |
| Q42504211 | IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus |
| Q46451352 | IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri |
| Q82645592 | MxiC is secreted by and controls the substrate specificity of the Shigella flexneri type III secretion apparatus |
| Q41466218 | MxiK and MxiN interact with the Spa47 ATPase and are required for transit of the needle components MxiH and MxiI, but not of Ipa proteins, through the type III secretion apparatus of Shigella flexneri |
| Q45282739 | Optimization of virulence functions through glucosylation of Shigella LPS. |
| Q54546861 | Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. |
| Q36267084 | Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors |
| Q37373930 | Shigella type III secretion effectors: how, where, when, for what purposes? |
| Q77937556 | Spa15 of Shigella flexneri, a third type of chaperone in the type III secretion pathway |
| Q27690286 | Structural basis for the inhibition of host protein ubiquitination by Shigella effector kinase OspG |
| Q24296380 | Structural mimicry for vinculin activation by IpaA, a virulence factor of Shigella flexneri |
| Q40101906 | Structure of Spa15, a type III secretion chaperone from Shigella flexneri with broad specificity |
| Q27652850 | Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases |
| Q84317090 | The 33 carboxyl-terminal residues of Spa40 orchestrate the multi-step assembly process of the type III secretion needle complex in Shigella flexneri |
| Q47439229 | The Evolutionary History of Shigella and Enteroinvasive Escherichia coli Revised |
| Q34048081 | The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes |
| Q35077170 | The various and varying roles of specific chaperones in type III secretion systems. |
| Q79293118 | Transcriptional slippage controls production of type III secretion apparatus components in Shigella flexneri |
| Q41850464 | Transcriptional slippage in mxiE controls transcription and translation of the downstream mxiD gene, which encodes a component of the Shigella flexneri type III secretion apparatus |
| Q43982547 | Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium |
| Q50066742 | Type III secretion effectors of the IpaH family are E3 ubiquitin ligases |
| Q82136498 | [Control of the host inflammatory response during Shigella flexneri infection] |
Search more.